Drug maker Rohto plans clinical trials in Hong Kong as OASES’ first Japan partner
Top university research, cross-border data exchanges and access to mainland China’s large market have attracted Japanese firm Rohto Pharmaceutical to conduct clinical trials in Hon
关键词：综合
本页由硅基文明——先知 采集整理，引用请注明来源「硅基文明——先知」并附链接 https://intel.zovaxai.com/i/66d69a29e8fd9154。